Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare data

被引:0
|
作者
Rahman, Fariha [1 ]
Osazuwa-Peters, Oyomoare L. [1 ]
Meernik, Clare [1 ]
Ward, Kevin C. [2 ]
Kuliszewski, Margaret G. [3 ]
Huang, Bin [4 ,5 ]
Berchuck, Andrew [6 ]
Tucker, Thomas [5 ,7 ]
Pisu, Maria [8 ,9 ]
Liang, Margaret [10 ]
Akinyemiju, Tomi F. [1 ,11 ]
机构
[1] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC 27708 USA
[2] Emory Univ, Georgia Canc Registry, Atlanta, GA USA
[3] New York State Dept Hlth, New York State Canc Registry, Albany, NY USA
[4] Univ Kentucky, Div Canc Biostat, Lexington, KY USA
[5] Univ Kentucky, Kentucky Canc Registry, Lexington, KY USA
[6] Duke Div Gynecol Oncol, Durham, NC USA
[7] Univ Kentucky, Dept Epidemiol & Environm Hlth, Lexington, KY USA
[8] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA
[9] Univ Alabama Birmingham, O Neal Comprehens Canc Ctr, Birmingham, AL USA
[10] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA USA
[11] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC USA
来源
SSM-MENTAL HEALTH | 2024年 / 6卷
基金
美国国家卫生研究院;
关键词
Ovarian cancer; Healthcare access; Racial disparities; Mental health; Mental health diagnosis; ETHNIC DISPARITIES; INSURANCE-COVERAGE; DEPRESSION; CARE; POPULATIONS; MORTALITY; DISTRESS; SURVIVAL; QUALITY; IMPACT;
D O I
10.1016/j.ssmmh.2024.100323
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Ovarian cancer (OC) patients have an increased risk for a mental health illness (MHI) after their cancer diagnosis, but limited research exists on whether this risk differs by race/ethnicity. Hence, we used SEERMedicare data to evaluate racial/ethnic differences in MHI incidence among OC patients aged 65+. Methods: Non-Hispanic (NH) Black, NH White, and Hispanic women diagnosed with OC in 2008-2015 without a mental health history 12 months prior to their cancer diagnosis were identified from SEER-Medicare. Cox proportional hazards regression evaluated new MHI incidence in the first five years post diagnosis and the differences by race/ethnicity. Hazard ratios (HR) and 95% confidence intervals (CI) adjusted for demographic/clinical covariates and healthcare access (HCA) dimensions. Results: We identified 5441 OC patients, including 364 NH Black (6.7%), 4982 NH White (91.6%), and 95 Hispanic (1.7%) patients. About 41% of NH White, 33.3% of NH Black, and 37.2% of Hispanic OC patients were diagnosed with MHI during the follow-up period between 2008 and 2016. In the fully adjusted model, NH Black OC patients were less likely to be diagnosed with any MHI (aHR: 0.67, 95% CI: 0.54, 0.82), depression (aHR: 0.66, 95% CI: 0.51, 0.86), and anxiety disorder (aHR: 0.64, 95% CI: 0.49, 0.84), while Hispanic OC patients were less likely to be diagnosed with anxiety disorder (aHR: 0.56, 95% CI: 0.33, 0.95) compared to NH White OC patients. Discussion: NH Black OC patients are less likely to receive a clinical MHI diagnosis compared to NH White OC patients. Further studies on racial differences in MHI incidence after OC diagnosis in primary cohorts are needed to better estimate population-level prevalence less vulnerable to exposure misclassification and to account for patient-level factors impacting MHI.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Raab, Gabriel T.
    Lin, Aijing
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Buono, Donna L.
    Hur, Chin
    Kiran, Ravi P.
    Wright, Jason D.
    Hershman, Dawn L.
    Neugut, Alfred I.
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : E294 - E299
  • [22] Racial disparities in outcome among head and neck cancer patients in the United States: An analysis using SEER-Medicare linked database.
    Suzuki, Ikumi
    Cullen, Kevin J.
    Mehra, Ranee
    Bentzen, Soren
    Goloubeva, Olga G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Does statin therapy improve ovarian cancer survival? A SEER-Medicare database analysis
    Vogel, T. J.
    Li, A. J.
    Jeon, C. Y.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 192 - 192
  • [24] Health Disparities in Staging of SEER-Medicare Prostate Cancer Patients in the United States
    Mullins, C. Daniel
    Onukwugha, Eberechukwu
    Bikov, Kaloyan
    Seal, Brian
    Hussain, Arif
    UROLOGY, 2010, 76 (03) : 566 - 572
  • [25] Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data
    Michels, Kara A.
    McNeel, Timothy S.
    Trabert, Britton
    GYNECOLOGIC ONCOLOGY, 2019, 155 (02) : 294 - 300
  • [26] Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis
    Guha, Avirup
    Fradley, Michael G.
    Dent, Susan F.
    Weintraub, Neal L.
    Lustberg, Maryam B.
    Alonso, Alvaro
    Addison, Daniel
    EUROPEAN HEART JOURNAL, 2022, 43 (04) : 300 - 312
  • [27] Treatment of localized prostate cancer: A survival analysis using seer-Medicare data
    Wong, YN
    Wan, F
    Mitra, N
    Localio, R
    Montagnet, C
    Hudes, G
    Armstrong, K
    JOURNAL OF UROLOGY, 2006, 175 (04): : 212 - 212
  • [28] HEALTH CARE RESOURCE UTILIZATION (HRU) IN ADVANCED OVARIAN CANCER-FINDINGS FROM LINKED SEER-MEDICARE DATA
    Parthan, A.
    Gao, S. K.
    Song, R.
    Borker, R.
    Langeberg, W. J.
    Teitelbaum, A.
    Oglesby, A.
    VALUE IN HEALTH, 2010, 13 (03) : A31 - A31
  • [29] Estimating health care costs related to cancer treatment from SEER-Medicare data
    Brown, ML
    Riley, GF
    Schussler, N
    Etzioni, R
    MEDICAL CARE, 2002, 40 (08) : 104 - 117
  • [30] Palliative care utilization and trends among patients with metastatic breast cancer: A SEER-Medicare analysis.
    Giap, Fantine
    Hong, Young-Rock
    Xie, Zhigang
    Li, Yujia
    Guo, Yi
    Bradley, Julie Ann
    Oladeru, Oluwadamilola Temilade
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 75 - 75